A stunning new study has confirmed what pro-life advocates have warned for decades: the abortion pill is not safe, and it’s harming women, many of them right here in Massachusetts.
The study, published by the Ethics and Public Policy Center (EPPC), is the largest real-world analysis ever conducted on the abortion pill, mifepristone. Drawing on all-payer insurance claims from more than 865,000 chemical abortions between 2017 and 2023, the research found that nearly 11% of women experienced serious adverse events, including hemorrhaging, sepsis, infection, or complications requiring surgery, within just 45 days of taking the pill.
To put that in perspective, that’s over 94,000 women facing severe, often life-threatening complications. These are not abstract statistics, these are real women, real pain, and real risks that have been minimized or outright ignored by the abortion industry and federal regulators.
Worse still, the EPPC report reveals that the true complication rate is 22 times higher than what’s reported on the FDA-approved drug label for mifepristone. This gross underreporting should outrage anyone concerned with medical ethics, transparency, and women’s health.
The implications for Massachusetts are deeply troubling. According to the Charlotte Lozier Institute, over 52% of all abortions in Massachusetts in 2022 were chemical abortions, that’s 9,276 mifepristone “procedures” in a single year.
That means potentially hundreds, if not thousands, of women in our state each year are exposed to these now-documented dangers, often with little or no medical supervision. Thanks to radical policies pushed by groups like Planned Parenthood and rubber-stamped by state lawmakers, abortion pills can be prescribed via telemedicine and even mailed directly to a woman’s home. There is no requirement in Massachusetts law that a woman receive an in-person examination before being handed a pill that could cause hemorrhaging, infection, or emergency surgery.
This is what the abortion industry calls “progress.” In reality, it’s a deeply irresponsible experiment on women’s bodies, and Massachusetts is helping to lead the charge.
For years, abortion advocates have insisted that mifepristone is “safer than Tylenol.” They’ve claimed it’s a simple, painless option that empowers women. But this new study exposes that narrative as a dangerous lie. With tens of thousands of women suffering complications, and the FDA still citing outdated safety data, this is not a healthcare system. It’s a political machine.
And yet, state leaders in Massachusetts continue to expand access to chemical abortion while refusing to acknowledge the risks. They’ve created “abortion access funds,” protected abortion providers from legal liability, and even codified abortion into state law, while women continue to suffer the consequences of half-truths and silence.
That’s why Massachusetts Family Institute joined over 100 organizations nationwide in signing a letter urging President Trump to investigate the FDA’s reckless approval and ongoing promotion of mifepristone. This letter, spearheaded by Family Research Council, demands answers on why the FDA continues to ignore mounting data and endanger women’s lives. You can read the full letter here.
Massachusetts women deserve to know the truth: the abortion pill is not safe. It’s time our leaders stopped playing politics with women’s lives and started demanding real oversight, real data, and real medical ethics.
Read the full study at StopHarmingWomen.org
Help MFI keep up the crucial fight to protect life and women in the Commonwealth. Give a generous donation today!
Share this blog by clicking the icons below!
